Routine Imaging for Diffuse Large B-Cell Lymphoma in First Complete Remission Does Not Improve Post-Treatment Survival: A Danish-Swedish Population-Based Study.

Research output: Contribution to journalArticle

Abstract

Routine imaging for diffuse large B-cell lymphoma (DLBCL) in first complete remission (CR) is controversial and plays a limited role in detecting relapse. This population-based study compared the survival of Danish and Swedish patients with DLBCL for whom traditions for routine imaging have been different.

Details

Authors
  • Tarec Christoffer El-Galaly
  • Lasse Hjort Jakobsen
  • Martin Hutchings
  • Peter de Nully Brown
  • Herman Nilsson-Ehle
  • Erzsébet Szekely
  • Karen Juul Mylam
  • Viktoria Hjalmar
  • Hans Erik Johnsen
  • Martin Bøgsted
  • Mats Jerkeman
Organisations
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Cancer and Oncology
Original languageEnglish
Pages (from-to)3993-3998
JournalJournal of Clinical Oncology
Volume33
Issue number34
Publication statusPublished - 2015
Publication categoryResearch
Peer-reviewedYes